Semaglutide
-
{
- All
- News
- Videos
- Web Stories
-
Fatty Liver Disease Is Rising Fast And Most People Don't Know They Have It
As India continues to grapple with rising rates of obesity, diabetes and other metabolic disorders, fatty liver disease can no longer be viewed as a niche liver condition or a problem restricted to major cities.
-
DIY Peptide Injections Are Risky, And People May Make Serious Mistakes When Administering Them
DIY peptide injections for weight loss and muscle gain pose serious health risks due to lack of regulation and potential contamination.
-
Serena Williams Defends GLP-1 Weight-Loss Drug Use: What Doctors Want You To Know
Serena Williams used GLP-1 medication Zepbound to lose weight and improve health post-pregnancy, highlighting obesity treatment options.
-
Ozempic Users Warned Over Hair Loss Linked to Weight Loss Jabs
Doctors have warned that some people using Ozempic and similar weight loss injections may experience hair loss, with experts linking the issue to rapid weight loss and possible nutritional deficiencies rather than the medication itself.
-
Why Are Indians Quitting Weight-Loss Drugs Despite Lower Prices?
Generic GLP-1 drugs are cheaper than ever, but many Indians aren't staying on treatment. Here's why doctors say retention, not affordability, is the real challenge.
-
Taking Ozempic? New Study Explains Why Pairing It With Exercise Is Important For Your Muscles
Researchers found that combining semaglutide with regular exercise led to greater fat loss and better overall results than using the medication alone.
-
Wegovy Pill Users Lost Up To 21.6% Weight In New Obesity Trial
The findings come from Novo Nordisk's phase 3 OASIS 4 clinical trial studying oral semaglutide 25 mg, the same active ingredient used in injectable Wegovy.
-
Wegovy Pill Users Lost Up To 21.6% Weight In New Obesity Trial
The findings come from Novo Nordisk's phase 3 OASIS 4 clinical trial studying oral semaglutide 25 mg, the same active ingredient used in injectable Wegovy.
-
Beyond GLP-1: New 5-In-1 Compound More Effective Than Semaglutide For Diabetes And Weight Loss
This innovative compound is known as a 'quintuple agonist' because it combines the power of GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists with lanifibranor.
-
Beyond GLP-1: New 5-In-1 Compound More Effective Than Semaglutide For Diabetes And Weight Loss
This innovative compound is known as a 'quintuple agonist' because it combines the power of GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists with lanifibranor.
-
Scientists Identify Protein Behind Ageing Joints In Arthritis Breakthrough
Stanford University scientists have identified a protein called 15-PGDH that drives cartilage breakdown with age, and shown that blocking it can restore worn joints in mice and human tissue.
-
Popular Weight Loss Drugs May Lead To More Muscle Loss, Finds Study
The study analysed multiple studies and found that muscle-related tissue accounted for about 35% of total weight lost in incretin groups, exceeding safe benchmarks in two-thirds of cases.
-
Popular Weight Loss Drugs May Lead To More Muscle Loss, Finds Study
The study analysed multiple studies and found that muscle-related tissue accounted for about 35% of total weight lost in incretin groups, exceeding safe benchmarks in two-thirds of cases.
-
Weight Loss Drugs May Be Making Patients Lose More Than Just Fat
UNC researchers found popular incretin drugs like semaglutide and tirzepatide are linked to unusually high muscle loss during weight loss.
-
From Ozempic To Bariatric Surgery, Delhi Doctor Ranks 7 Weight-Loss Methods
Not everyone can or should opt for Ozempic, Mounjaro, or bariatric surgery for weight loss. The doctor lists seven methods and explains who they suit best
-
Fatty Liver Disease Is Rising Fast And Most People Don't Know They Have It
As India continues to grapple with rising rates of obesity, diabetes and other metabolic disorders, fatty liver disease can no longer be viewed as a niche liver condition or a problem restricted to major cities.
-
DIY Peptide Injections Are Risky, And People May Make Serious Mistakes When Administering Them
DIY peptide injections for weight loss and muscle gain pose serious health risks due to lack of regulation and potential contamination.
-
Serena Williams Defends GLP-1 Weight-Loss Drug Use: What Doctors Want You To Know
Serena Williams used GLP-1 medication Zepbound to lose weight and improve health post-pregnancy, highlighting obesity treatment options.
-
Ozempic Users Warned Over Hair Loss Linked to Weight Loss Jabs
Doctors have warned that some people using Ozempic and similar weight loss injections may experience hair loss, with experts linking the issue to rapid weight loss and possible nutritional deficiencies rather than the medication itself.
-
Why Are Indians Quitting Weight-Loss Drugs Despite Lower Prices?
Generic GLP-1 drugs are cheaper than ever, but many Indians aren't staying on treatment. Here's why doctors say retention, not affordability, is the real challenge.
-
Taking Ozempic? New Study Explains Why Pairing It With Exercise Is Important For Your Muscles
Researchers found that combining semaglutide with regular exercise led to greater fat loss and better overall results than using the medication alone.
-
Wegovy Pill Users Lost Up To 21.6% Weight In New Obesity Trial
The findings come from Novo Nordisk's phase 3 OASIS 4 clinical trial studying oral semaglutide 25 mg, the same active ingredient used in injectable Wegovy.
-
Wegovy Pill Users Lost Up To 21.6% Weight In New Obesity Trial
The findings come from Novo Nordisk's phase 3 OASIS 4 clinical trial studying oral semaglutide 25 mg, the same active ingredient used in injectable Wegovy.
-
Beyond GLP-1: New 5-In-1 Compound More Effective Than Semaglutide For Diabetes And Weight Loss
This innovative compound is known as a 'quintuple agonist' because it combines the power of GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists with lanifibranor.
-
Beyond GLP-1: New 5-In-1 Compound More Effective Than Semaglutide For Diabetes And Weight Loss
This innovative compound is known as a 'quintuple agonist' because it combines the power of GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists with lanifibranor.
-
Scientists Identify Protein Behind Ageing Joints In Arthritis Breakthrough
Stanford University scientists have identified a protein called 15-PGDH that drives cartilage breakdown with age, and shown that blocking it can restore worn joints in mice and human tissue.
-
Popular Weight Loss Drugs May Lead To More Muscle Loss, Finds Study
The study analysed multiple studies and found that muscle-related tissue accounted for about 35% of total weight lost in incretin groups, exceeding safe benchmarks in two-thirds of cases.
-
Popular Weight Loss Drugs May Lead To More Muscle Loss, Finds Study
The study analysed multiple studies and found that muscle-related tissue accounted for about 35% of total weight lost in incretin groups, exceeding safe benchmarks in two-thirds of cases.
-
Weight Loss Drugs May Be Making Patients Lose More Than Just Fat
UNC researchers found popular incretin drugs like semaglutide and tirzepatide are linked to unusually high muscle loss during weight loss.
-
From Ozempic To Bariatric Surgery, Delhi Doctor Ranks 7 Weight-Loss Methods
Not everyone can or should opt for Ozempic, Mounjaro, or bariatric surgery for weight loss. The doctor lists seven methods and explains who they suit best
